Back to Journals » Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy » Volume 12

Optimizing glycemic control in type 2 diabetic patients through the use of a low-carbohydrate, high-fat, ketogenic diet: a review of two patients in primary care

Authors Rallis S

Received 26 November 2018

Accepted for publication 11 January 2019

Published 5 March 2019 Volume 2019:12 Pages 299—303

DOI https://doi.org/10.2147/DMSO.S195994

Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Dr Andrew Yee

Peer reviewer comments 2

Editor who approved publication: Dr Juei-Tang Cheng


Video abstract presented by Stefan Rallis.

Views: 136

Stefan Rallis

Dr. Rallis Wellness Group, Barrie, ON, Canada

Abstract: Established guidelines continue to promote carbohydrate-rich (>130 g/day) diets in the primary-care management of type 2 diabetic (DM2) patients. A growing body of evidence suggests that a low-carbohydrate, high-fat, ketogenic diet (KD) may be a more effective nutritional strategy for improving glycemic control. Two diabetic patients, a 65-year-old female and a 52-year-old male, were placed on KDs consisting of 70% fat, 20%–25% protein, and 5%–10% carbohydrates and monitored for 12 weeks. The 65-year-old female demonstrated a 2.4% reduction in HBA1C over 12 weeks while reducing her diabetic medication by 75%. The 52-year-old male demonstrated a 2.5% reduction in HBA1C while eliminating all diabetic medications. These cases demonstrate the efficacy of KDs in terms of improving glycemic control in DM2 patients and lend support to the increased use of KDs in this population cohort.

Keywords: case series, diabetes, HBA1C, improved glycemic control

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]